Updated:
NIHON KOHDEN CORPORATION
Nihon Kohden, the Japanese medical-device company behind the pulse oximeter's IEEE-recognized principle, invests corporate capital in healthcare technologies.
NIHON KOHDEN CORPORATION
General information
Firm type
Asset Manager
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Sector focus
Frequently asked questions
What is Nihon Kohden's primary business that generates investable capital?
Nihon Kohden is a medical device manufacturer whose principal revenue engines are patient monitoring systems, electroencephalographs, electrocardiographs, and public-access automated external defibrillators (AEDs). The company pioneered pulse oximetry technology — a discovery the IEEE recognized with a Milestone award — and sells into hospital, emergency-services, and home-care channels globally.
Why was the pulse oximeter milestone relevant to Nihon Kohden's investment profile?
The IEEE Milestone designation validates Nihon Kohden's foundational role in a technology now standard in operating rooms, intensive care units, and home monitoring worldwide. That legacy IP creates a durable brand moat and generates recurring consumable and hardware revenue, which funds the firm's ongoing innovation and capital allocation pipeline.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: